Titilayo Ilori is a Nephrology physician affiliated with Boston Medical Center. OpenAlex indexes 73 publications with 1,189 citations (h-index 15); ClinicalTrials.gov lists 1 registered study matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
725 Albany Street, Suite 7a
Shapiro Bldg
Boston, MA 021182528
Telephone
617-414-8680Provider last certified this registry record 9 Apr 2024.
Clinical trials
- Metformin and Congenital Nephrogenic Diabetes Insipidus
Sponsor: Emory University
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Medicare prescribing footprint (2022)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Metabolism & gastrointestinal
52%Vitamin D3 Analog52%Calcitriol100%Part D<11 patientsCardiovascular
48%Beta blocker26%Carvedilol100%Part D<11 patientsLoop diuretic22%Furosemide100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
3 NIH research awards on record, funded 2020–2026 per NIH RePORTER. The latest:
- ApolipoproteinL1 Genotypes and Biomarkers of Immune Activation and Tubular Injury
Boston Medical Center
FY2025$133,500R03DK140290 - The Role of Dietary Nutrients in Chronic Kidney Disease Progression and Apolipoprotein L1 Nephropathy
Boston Medical Center
FY2024$185,132K23DK119542
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Defining Kidney Health Dimensions and Their Associations with Adverse Outcomes in Persons with Diabetes and CKD
Clinical Journal of the American Society of Nephrology
2025 - Association of Dietary Sodium and Potassium With Blood Pressure and Proteinuria in Africans With Kidney Disease
Kidney International Reports
2025 - <i>APOL1</i> Bi- and Monoallelic Variants and Chronic Kidney Disease in West Africans
New England Journal of Medicine
2024
Similar KOLs
Other experts from the same institution or the same specialty.
Alice Jacobs, MD
Boston Medical Center
Carlos Kase, MD
Boston Medical Center
Sushrut Waikar, MD
Boston Medical Center
Geoffrey Oxnard, MD
Boston Medical Center
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”